Trademark: 90324496
Status Date
Monday, February 27, 2023
Filing Date
Tuesday, November 17, 2020
Published for Opposition
Tuesday, June 1, 2021
Abandoned Date
Monday, February 27, 2023
5 General and subcutaneous injectable pharmaceuticals for the treatment of the immune system
The wording "INFEPERIUM" has no meaning in a foreign language.
Feb 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 27, 2023
Abandonment - No Use Statement Filed
Jun 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2022
Sou Extension 2 Granted
Jun 14, 2022
Sou Extension 2 Filed
Jun 14, 2022
Teas Extension Received
Dec 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 28, 2021
Sou Extension 1 Granted
Dec 28, 2021
Sou Extension 1 Filed
Dec 28, 2021
Teas Extension Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 29, 2021
Approved For Pub - Principal Register
Apr 28, 2021
Examiner's Amendment Entered
Apr 28, 2021
Notification Of Examiners Amendment E-Mailed
Apr 28, 2021
Examiners Amendment E-Mailed
Apr 28, 2021
Examiners Amendment -Written
Apr 28, 2021
Assigned To Examiner
Jan 16, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24